Search
Newsroom
Science Center - ChiShiki
Careers
Contact
About Us
About Sosei Heptares
Celebrating 30 Years
What's in a name
Mission, Vision, Values
Management Team
Our Board of Directors
Our Partners
Corporate Details
Locations
Contact
Our Science
Our Science
What are GPCRs
Proprietary Research Platform
Clinical Data and Presentations
Scientific Collaborations
Scientific Advisory Board
Intellectual Property
Science Center - CHISHIKI
Our Pipeline
R&D Pipeline
In-house Programs
Partnered Programs
Our Medicines
Our Medicines
Ultibro® and Seebri®
Enerzair® Breezhaler®
ORAVI®
Minority Investments
RNA Therapeutics
MiNA Tx
Peptide Synthesis
Jitsubo
Regenerative Medicine Fund
Investors
Why invest in us
Investment highlights
Online investor kit
Disclosure Policy
Newsroom
Press releases
Publications
Events
Financial & IR Information
Financial Highlights
Financial Results
Presentations and Webcasts
Securities Reports
Stock Information
Share Price Chart
General Stock Information
Shareholder's Meetings & Publications
Analyst Coverage
Articles of Incorporation
Sustainability
Email Alerts
Contact IR
Search
Newsroom
Science Center - ChiShiki
Careers
Contact
About Us
About Sosei Heptares
Celebrating 30 Years
What's in a name
Mission, Vision, Values
Management Team
Our Board of Directors
Our Partners
Corporate Details
Locations
Contact
Our Science
Our Science
What are GPCRs
Proprietary Research Platform
Clinical Data and Presentations
Scientific Collaborations
Scientific Advisory Board
Intellectual Property
Science Center - CHISHIKI
Our Pipeline
R&D Pipeline
In-house Programs
Partnered Programs
Our Medicines
Our Medicines
Ultibro® and Seebri®
Enerzair® Breezhaler®
ORAVI®
Minority Investments
RNA Therapeutics
MiNA Tx
Peptide Synthesis
Jitsubo
Regenerative Medicine Fund
Investors
Why invest in us
Investment highlights
Online investor kit
Disclosure Policy
Newsroom
Press releases
Publications
Events
Financial & IR Information
Financial Highlights
Financial Results
Presentations and Webcasts
Securities Reports
Stock Information
Share Price Chart
General Stock Information
Shareholder's Meetings & Publications
Analyst Coverage
Articles of Incorporation
Sustainability
Email Alerts
Contact IR
Search
Newsroom
Science Center - ChiShiki
Careers
Contact
Press release
Why invest in us
Investment highlights
Online investor kit
Disclosure Policy
Newsroom
Press releases
Publications
Events
Financial & IR Information
Financial Highlights
Financial Results
Presentations and Webcasts
Securities Reports
Stock Information
Share Price Chart
General Stock Information
Shareholder's Meetings & Publications
Analyst Coverage
Articles of Incorporation
Sustainability
Email Alerts
Contact IR
Jan 5, 2021
Regains Worldwide Rights to Muscarinic Agonist Programs - Presentation and Webcast
Regains Worldwide Rights to Muscarinic Agonist Programs - Presentation and Webcast
DOWNLOAD PDF
Return
DOWNLOAD PDF